Clinical trial
The Effect of Tranexamic Acid in Anticoagulated Patients Undergoing Total Shoulder Athroplasty
NCT04560010 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Tranexamic Acid in Anticoagulated Patients Undergoing Total Shoulder Athroplasty
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 6, 2020
- Completion date
- March 11, 2023
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
total shoulder athroplasty